Clinical Trials Logo

Rejection; Transplant, Liver clinical trials

View clinical trials related to Rejection; Transplant, Liver.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05234190 Recruiting - Liver Diseases Clinical Trials

Safety and Clinical Activity of QEL-001 in A2-mismatch Liver Transplant Patients

LIBERATE
Start date: January 21, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and tolerability of QEL-001 in the prevention of liver transplant rejection following immunosuppression withdrawal. QEL-001 is a product made from a patients own cells, which are genetically modified and designed to help the transplant recipient's body accept their donated liver and prevent their immune system from rejecting it once immune suppression is withdrawn.

NCT ID: NCT04838171 Recruiting - Inflammation Clinical Trials

Prospective Study of White Blood Cells

Start date: March 24, 2021
Phase:
Study type: Observational

The purpose of this study is to investigate white blood cells from volunteering donors to support the development of engineered regulatory T cell therapies.